Upstream Bio, Inc. (NASDAQ:UPB – Get Free Report) Director Erez Chimovits bought 825,000 shares of Upstream Bio stock in a transaction on Tuesday, October 15th. The shares were acquired at an average cost of $17.00 per share, for a total transaction of $14,025,000.00. Following the completion of the acquisition, the director now directly owns 4,554,873 shares in the company, valued at approximately $77,432,841. The trade was a 0.00 % increase in their ownership of the stock. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website.
Upstream Bio Stock Performance
Shares of Upstream Bio stock opened at $25.88 on Friday. Upstream Bio, Inc. has a twelve month low of $20.74 and a twelve month high of $26.88.
Upstream Bio Company Profile
Read More
- Five stocks we like better than Upstream Bio
- Stock Average Calculator
- Survey Reveals: America’s Most Coveted Businesses in 2024
- TSX Venture Exchange (Formerly Canadian Venture Exchange)
- Top 3 Stocks to Play Oil’s Potential Comeback Rally
- How to Invest in Insurance Companies: A Guide
- Analysts See Growth in CrowdStrike Stock Despite July Setback
Receive News & Ratings for Upstream Bio Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Upstream Bio and related companies with MarketBeat.com's FREE daily email newsletter.